Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M M Ames

Showing results (81-90 of 90) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 90 results.
Medical and Pediatric Oncology|December 1, 1996
Comparison of idarubicin to daunomycin in a randomized multidrug treatment of childhood acute lymphoblastic leukemia at first bone marrow relapse: a report from the Children's Cancer GroupS A Feig, M M Ames, H N Sather, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 1998
6-Aminonicotinamide sensitizes human tumor cell lines to cisplatinI I Budihardjo, D L Walker, P A Svingen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 1, 1999
Phase I trial of dolastatin-10 (NSC 376128) in patients with advanced solid tumorsH C Pitot, E A McElroy, J M Reid, et al.
Biochemical Pharmacology|October 6, 1999
Murine pharmacokinetics of 6-aminonicotinamide (NSC 21206), a novel biochemical modulating agentD L Walker, J M Reid, P A Svingen, et al.
Blood|November 10, 1998
Pharmacokinetics and pharmacodynamics of oral methotrexate and mercaptopurine in children with lower risk acute lymphoblastic leukemia: a joint children's cancer group and pediatric oncology branch studyF M Balis, J S Holcenberg, D G Poplack, et al.
Journal of Neuro-Oncology|February 24, 2001
A randomized phase II and pharmacokinetic study of dacarbazine in patients with recurrent gliomaS V Rajkumar, J M Reid, P J Novotny, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 24, 2001
A phase I clinical, pharmacological, and biological trial of interleukin 6 plus granulocyte-colony stimulating factor after ifosfamide, carboplatin, and etoposide in children with recurrent/refractory solid tumors: enhanced hematological responses but a high incidence of grade III/IV constitutional toxicitiesF Bracho, M D Krailo, V Shen, et al.
Clinical Pharmacology and Therapeutics|November 1, 2007
Preclinical pharmacology and toxicology of intravenous MV-NIS, an oncolytic measles virus administered with or without cyclophosphamideR M Myers, S M Greiner, M E Harvey, et al.
Bone Marrow Transplantation|August 4, 2009
Phase I trial of autologous hematopoietic SCT with escalating doses of topotecan combined with CY and carboplatin in patients with relapsed or persistent ovarian or primary peritoneal carcinomaM R Litzow, P P Peethambaram, S L Safgren, et al.
Clinical Pharmacology and Therapeutics|September 25, 2013
CYP2D6 genotype and adjuvant tamoxifen: meta-analysis of heterogeneous study populationsM A Province, M P Goetz, H Brauch, et al.
Pageof 9

Showing results (81-90 of 90) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 90 results.
Medical and Pediatric Oncology|December 1, 1996
Comparison of idarubicin to daunomycin in a randomized multidrug treatment of childhood acute lymphoblastic leukemia at first bone marrow relapse: a report from the Children's Cancer GroupS A Feig, M M Ames, H N Sather, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 1998
6-Aminonicotinamide sensitizes human tumor cell lines to cisplatinI I Budihardjo, D L Walker, P A Svingen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 1, 1999
Phase I trial of dolastatin-10 (NSC 376128) in patients with advanced solid tumorsH C Pitot, E A McElroy, J M Reid, et al.
Biochemical Pharmacology|October 6, 1999
Murine pharmacokinetics of 6-aminonicotinamide (NSC 21206), a novel biochemical modulating agentD L Walker, J M Reid, P A Svingen, et al.
Blood|November 10, 1998
Pharmacokinetics and pharmacodynamics of oral methotrexate and mercaptopurine in children with lower risk acute lymphoblastic leukemia: a joint children's cancer group and pediatric oncology branch studyF M Balis, J S Holcenberg, D G Poplack, et al.
Journal of Neuro-Oncology|February 24, 2001
A randomized phase II and pharmacokinetic study of dacarbazine in patients with recurrent gliomaS V Rajkumar, J M Reid, P J Novotny, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 24, 2001
A phase I clinical, pharmacological, and biological trial of interleukin 6 plus granulocyte-colony stimulating factor after ifosfamide, carboplatin, and etoposide in children with recurrent/refractory solid tumors: enhanced hematological responses but a high incidence of grade III/IV constitutional toxicitiesF Bracho, M D Krailo, V Shen, et al.
Clinical Pharmacology and Therapeutics|November 1, 2007
Preclinical pharmacology and toxicology of intravenous MV-NIS, an oncolytic measles virus administered with or without cyclophosphamideR M Myers, S M Greiner, M E Harvey, et al.
Bone Marrow Transplantation|August 4, 2009
Phase I trial of autologous hematopoietic SCT with escalating doses of topotecan combined with CY and carboplatin in patients with relapsed or persistent ovarian or primary peritoneal carcinomaM R Litzow, P P Peethambaram, S L Safgren, et al.
Clinical Pharmacology and Therapeutics|September 25, 2013
CYP2D6 genotype and adjuvant tamoxifen: meta-analysis of heterogeneous study populationsM A Province, M P Goetz, H Brauch, et al.
Pageof 9